Ad
related to: moderna stock price
Search results
Results From The WOW.Com Content Network
The company's stock was trading slightly up on the news early Monday before falling after market open. Moderna is up almost 20% in the last month after the company received approval from the FDA ...
Shares of Moderna soared around 14% on Thursday on the news that a personalized cancer vaccine, produced in partnership with Merck, reduced the risk of late-stage melanoma by 49%.
A relative unknown in the pharmaceutical space pre-pandemic, Moderna stock virtually skyrocketed from $45.99 per share on April 1, 2020, to $236.44 in mid-July 2021, which is close to the one-year ...
Moderna's coronavirus-related revenue dropped off a cliff, dragging down its bottom line (and its stock price along with it). However, several developments may suggest that it is still worth ...
Moderna, Inc. ( / məˈdɜːrnə / mə-DUR-nə) [4] is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response.
Moderna Current Valuation and Performance. Moderna stock sits at $146.36 per share as of Feb. 17, 2022. Depending on which analyst you believe, you should expect either a loss of 42% or gains of ...
Moderna. Stock price as of Dec. 8, 2021: $283.40. Moderna’s revenue numbers pale in comparison to Pfizer, but investors who chose Moderna over Pfizer are much happier.
Moderna (MRNA) stock has been one of 2020’s star performers, up 695%, and judging by its real-world results, many would say justifiably so.The biggest question for investors, then, is whether ...
Ad
related to: moderna stock price